Researchers discover how a gene mutation in the cancerous tumor leads to cell cycle dysregulation and heightened sensitivity to a class of inhibitors.

The discovery reveals how bacteria silence potentially deadly genes.

A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.

A newly developed tool is studying the genetics underlying the emerging fungal pathogen, Candida auris.

A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma.

Mouse model reveals gut inflammation makes it easier for bacterium to set up shop.